January 23rd, 2014
Prevention Guidelines in Practice: Vignette 2
Andrew M. Kates, MD
This vignette is the second in our series “Making Sense of the New Prevention Guidelines — The View from Clinical Practice” A 45-year-old man sees you for cardiac risk assessment. His father died at age 42 from a myocardial infarction. He exercises regularly and feels he eats well. He does not smoke. His blood pressure is […]
December 11th, 2013
Inside The KDIGO Guideline On Lipid Management In Patients With CKD
Marcello Tonelli, MD, SM and Harlan M. Krumholz, MD, SM
Recently the Kidney Disease Improving Global Outcomes (KDIGO) Lipid Management in Patients with Chronic Kidney Disease Guideline was published in Kidney International. Now a synopsis has appeared in the Annals of Internal Medicine. Harlan Krumholz spoke with the co-chairman of the guideline, Marcello Tonelli. Krumholz: Like the new US Guidelines, the KDIGO Guideline abandons targets. Were you aware of the US Guidelines or did […]
NEJM Journal Watch — Recent Cardiology Articles- Is Diltiazem Safe in Patients with AF Taking Apixaban or Rivaroxaban?
- Does Lowering High Childhood Lipid Levels Prevent Adverse Cardiovascular Events in Adulthood?
- Self-Expanding Supraannular Valve vs. Balloon-Expandable Valve in TAVR for Small Aortic Annulus
- A New TAVR Prosthesis for Aortic Regurgitation Shows Promise
- Aprocitentan, a Newly Approved Drug for Resistant Hypertension